Viewing Study NCT05362760


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-25 @ 10:03 PM
Study NCT ID: NCT05362760
Status: RECRUITING
Last Update Posted: 2025-05-16
First Post: 2022-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
Sponsor: Prof. Wolfgang Janni
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module